Research Topics
| Lone BaandrupSummaryAffiliation: Center for Neuropsychiatric Schizophrenia Research Country: Denmark Publications
|
Detail Information
Publications
Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: a population-based nested case-control studyLone Baandrup
Centre for Neuropsychiatric Schizophrenia Research, Psychiatric Centre Glostrup, Copenhagen University Hospital, Glostrup, Nordre Ringvej 29 67, DK 2600 Glostrup, Denmark
J Clin Psychiatry 71:103-8. 2010..The objective was to investigate if antipsychotic polypharmacy is associated with the excess mortality from natural causes among patients with schizophrenia...
Evaluation of a multifaceted intervention to limit excessive antipsychotic co-prescribing in schizophrenia out-patientsLone Baandrup
Center for Neuropsychiatric Schizophrenia Research, Copenhagen University Hospital, Psychiatric Center Glostrup, Glostrup, Denmark
Acta Psychiatr Scand 122:367-74. 2010..To evaluate the effect of a multifaceted educational intervention on the frequency of antipsychotic co-prescribing in adult schizophrenia out-patients...
Exploring regional variation in antipsychotic coprescribing practice: a Danish questionnaire surveyLone Baandrup
Center for Neuropsychiatric Schizophrenia Research, Copenhagen University Hospital, Psychiatric Center Glostrup, Nordre Ringvej 29 67, DK 2600 Glostrup, Denmark
J Clin Psychiatry 71:1457-64. 2010..The aim of the present study was to investigate regional differences in treatment setting characteristics and in physician and nurse attitudes toward antipsychotic polypharmacy and clinical guidelines...
Association of antipsychotic polypharmacy with health service cost: a register-based cost analysisLone Baandrup
Centre for Neuropsychiatric Schizophrenia Research, Copenhagen University Hospital, Mental Health Services Capital Region of Denmark, Glostrup, Nordre Ringvej 29 67, 2600 Glostrup, Denmark
Eur J Health Econ 13:355-63. 2012..To investigate the association of antipsychotic polypharmacy in schizophrenia with cost of primary and secondary health service use...
Prolonged-release melatonin versus placebo for benzodiazepine discontinuation in patients with schizophrenia: a randomized clinical trial - the SMART trial protocolLone Baandrup
Center for Neuropsychiatric Schizophrenia Research CNSR and Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research CINS, University of Copenhagen, Mental Health Centre Glostrup, Mental Health Services Capital Region of Denmark, Glostrup, Denmark
BMC Psychiatry 11:160. 2011..Furthermore, we aim to investigate the association of benzodiazepine dose reduction with the following clinically important variables: sleep, psychophysiology, cognition, social function, and quality of life...
